IRF8
Interferon regulatory factor 8
Also known as: ICSBP, ICSBP1, IRF-8, IRF8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02556
- Gene
- IRF8
- Ensembl
- ENSG00000140968
- Chromosome
- 16
- Canonical length
- 426 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
426 residues, UniProt reviewed canonical sequence.
>Q02556|IRF8
1 MCDRNGGRRL RQWLIEQIDS SMYPGLIWEN EEKSMFRIPW KHAGKQDYNQ EVDASIFKAW
61 AVFKGKFKEG DKAEPATWKT RLRCALNKSP DFEEVTDRSQ LDISEPYKVY RIVPEEEQKC
121 KLGVATAGCV NEVTEMECGR SEIDELIKEP SVDDYMGMIK RSPSPPEACR SQLLPDWWAQ
181 QPSTGVPLVT GYTTYDAHHS AFSQMVISFY YGGKLVGQAT TTCPEGCRLS LSQPGLPGTK
241 LYGPEGLELV RFPPADAIPS ERQRQVTRKL FGHLERGVLL HSSRQGVFVK RLCQGRVFCS
301 GNAVVCKGRP NKLERDEVVQ VFDTSQFFRE LQQFYNSQGR LPDGRVVLCF GEEFPDMAPL
361 RSKLILVQIE QLYVRQLAEE AGKSCGAGSV MQAPEEPPPD QVFRMFPDIC ASHQRSFFRE
421 NQQITVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IRF8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 196 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 196 nTPM
- tonsil: 174 nTPM
- spleen: 104 nTPM
- appendix: 63 nTPM
- small intestine: 58 nTPM
- thymus: 53 nTPM
Single-cell type
- pdcs: 1,307 nCPM
- b-cells: 390 nCPM
- cdc: 357 nCPM
- kupffer cells: 198 nCPM
- microglia: 183 nCPM
- macrophages: 159 nCPM
Immune cell
- plasmacytoid DC: 2,405 nTPM
- naive B-cell: 349 nTPM
- memory B-cell: 336 nTPM
- myeloid DC: 285 nTPM
- total PBMC: 143 nTPM
- classical monocyte: 133 nTPM
Brain region
- white matter: 17 nTPM
- thalamus: 15 nTPM
- spinal cord: 13 nTPM
- medulla oblongata: 12 nTPM
- pons: 12 nTPM
- midbrain: 9.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IRF8.
Disease | AllUniProt
Conditions IRF8 is implicated in, by any mechanism.
- Immunodeficiency 32A (IMD32A) MIM:614893
- Immunodeficiency 32B (IMD32B) MIM:226990
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 439 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency
- Immunodeficiency 32B
- Esophageal atresia/tracheoesophageal fistula
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.95
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagy
- cellular response to lipopolysaccharide
- cellular response to type II interferon
- defense response to bacterium
- defense response to protozoan
- dendritic cell differentiation
- follicular B cell differentiation
- germinal center B cell differentiation
- immune response
- immune system process
- myeloid cell differentiation
- negative regulation of transcription by RNA polymerase II
- phagocytosis
- plasmacytoid dendritic cell differentiation
- positive regulation of apoptotic process
- positive regulation of interleukin-12 production
- positive regulation of transcription by RNA polymerase II
- positive regulation of type II interferon production
- regulation of transcription by RNA polymerase II
- regulation of type I interferon production
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Interferon regulatory factor, DNA-binding domain
- SMAD/FHA domain superfamily
- SMAD-like domain superfamily
- Interferon regulatory factor-3
- Interferon regulatory factor, conserved site
- Winged helix-like DNA-binding domain superfamily
- Winged helix DNA-binding domain superfamily
- Interferon regulatory factor transcription factor
- Interferon-regulatory factor 3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IRF8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IRF8 as an antibody target. Whether an autoantibody or antibody against IRF8 could matter depends on whether native IRF8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IRF8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IRF8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...